BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 15564292)

  • 1. Prostaglandin E receptor subtype EP(1) deficiency inhibits colon cancer development.
    Kawamori T; Kitamura T; Watanabe K; Uchiya N; Maruyama T; Narumiya S; Sugimura T; Wakabayashi K
    Carcinogenesis; 2005 Feb; 26(2):353-7. PubMed ID: 15564292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of prostaglandin E receptor subtype EP(4) in colon carcinogenesis.
    Mutoh M; Watanabe K; Kitamura T; Shoji Y; Takahashi M; Kawamori T; Tani K; Kobayashi M; Maruyama T; Kobayashi K; Ohuchida S; Sugimoto Y; Narumiya S; Sugimura T; Wakabayashi K
    Cancer Res; 2002 Jan; 62(1):28-32. PubMed ID: 11782353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Downregulation of prostaglandin E receptor subtype EP3 during colon cancer development.
    Shoji Y; Takahashi M; Kitamura T; Watanabe K; Kawamori T; Maruyama T; Sugimoto Y; Negishi M; Narumiya S; Sugimura T; Wakabayashi K
    Gut; 2004 Aug; 53(8):1151-8. PubMed ID: 15247185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostaglandin E receptor EP3 deficiency modifies tumor outcome in mouse two-stage skin carcinogenesis.
    Shoji Y; Takahashi M; Takasuka N; Niho N; Kitamura T; Sato H; Maruyama T; Sugimoto Y; Narumiya S; Sugimura T; Wakabayashi K
    Carcinogenesis; 2005 Dec; 26(12):2116-22. PubMed ID: 16051640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strain differences in the susceptibility to azoxymethane and dextran sodium sulfate-induced colon carcinogenesis in mice.
    Suzuki R; Kohno H; Sugie S; Nakagama H; Tanaka T
    Carcinogenesis; 2006 Jan; 27(1):162-9. PubMed ID: 16081511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Indole-3-carbinol inhibits the growth of human colon carcinoma cells but enhances the tumor multiplicity and volume of azoxymethane-induced rat colon carcinogenesis.
    Suzui M; Inamine M; Kaneshiro T; Morioka T; Yoshimi N; Suzuki R; Kohno H; Tanaka T
    Int J Oncol; 2005 Nov; 27(5):1391-9. PubMed ID: 16211236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COX-2 and prostanoid receptors: good targets for chemoprevention.
    Kawamori T; Wakabayashi K
    J Environ Pathol Toxicol Oncol; 2002; 21(2):149-53. PubMed ID: 12086401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of colon carcinogenesis by prostaglandin E2 administration.
    Kawamori T; Uchiya N; Sugimura T; Wakabayashi K
    Carcinogenesis; 2003 May; 24(5):985-90. PubMed ID: 12771044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of long-term administration of sulindac on APC mRNA and apoptosis in colons of rats treated with azoxymethane.
    Kishimoto Y; Yashima K; Morisawa T; Ohishi T; Marumoto A; Sano A; Idobe-Fujii Y; Miura N; Shiota G; Murawaki Y; Hasegawa J
    J Cancer Res Clin Oncol; 2002 Nov; 128(11):589-95. PubMed ID: 12458338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Strain-specific homeostatic responses during early stages of Azoxymethane-induced colon tumorigenesis in mice.
    Guda K; Marino JN; Jung Y; Crary K; Dong M; Rosenberg DW
    Int J Oncol; 2007 Oct; 31(4):837-42. PubMed ID: 17786315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemopreventive effects of lupulone, a hop {beta}-acid, on human colon cancer-derived metastatic SW620 cells and in a rat model of colon carcinogenesis.
    Lamy V; Roussi S; Chaabi M; Gossé F; Schall N; Lobstein A; Raul F
    Carcinogenesis; 2007 Jul; 28(7):1575-81. PubMed ID: 17434926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of expression of the EP2 but not EP3 receptor for prostaglandin E2 results in suppression of skin tumor development.
    Sung YM; He G; Fischer SM
    Cancer Res; 2005 Oct; 65(20):9304-11. PubMed ID: 16230392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-mutagenic lichen extract has double-edged effect on azoxymethane-induced colorectal oncogenesis in C57BL/6J mice.
    He X; Hu Y; Winter J; Young GP
    Toxicol Mech Methods; 2010 Jan; 20(1):31-5. PubMed ID: 20030572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of development of azoxymethane-induced colonic premalignant lesions in C57BL/KsJ-db/db mice.
    Hirose Y; Hata K; Kuno T; Yoshida K; Sakata K; Yamada Y; Tanaka T; Reddy BS; Mori H
    Carcinogenesis; 2004 May; 25(5):821-5. PubMed ID: 14729596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Supplementation with branched-chain amino acids inhibits azoxymethane-induced colonic preneoplastic lesions in male C57BL/KsJ-db/db mice.
    Shimizu M; Shirakami Y; Iwasa J; Shiraki M; Yasuda Y; Hata K; Hirose Y; Tsurumi H; Tanaka T; Moriwaki H
    Clin Cancer Res; 2009 May; 15(9):3068-75. PubMed ID: 19366832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A high-fat diet enhances the inhibitory effect of dietary vitamin B6 on colon cell proliferation in mice.
    Komatsu S; Isobe M; Yanaka N; Kato N
    Oncol Rep; 2005 Jul; 14(1):265-9. PubMed ID: 15944799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simultaneous exposure to dietary acrylamide and corn oil developed carcinogenesis through cell proliferation and inhibition of apoptosis by regulating p53-mediated mitochondria-dependent signaling pathway.
    Zhang X
    Toxicol Ind Health; 2009 Mar; 25(2):101-9. PubMed ID: 19458132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of azoxymethane-induced colon cancer development in rats by a prostaglandin E receptor EP1-selective antagonist.
    Niho N; Mutoh M; Kitamura T; Takahashi M; Sato H; Yamamoto H; Maruyama T; Ohuchida S; Sugimura T; Wakabayashi K
    Cancer Sci; 2005 May; 96(5):260-4. PubMed ID: 15904466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The potential of sphingomyelin as a chemopreventive agent in AOM-induced colon cancer model: wild-type and p53+/- mice.
    Hu Y; Le Leu RK; Belobrajdic D; Young GP
    Mol Nutr Food Res; 2008 May; 52(5):558-66. PubMed ID: 18324704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective role of luteolin on the status of lipid peroxidation and antioxidant defense against azoxymethane-induced experimental colon carcinogenesis.
    Ashokkumar P; Sudhandiran G
    Biomed Pharmacother; 2008 Nov; 62(9):590-7. PubMed ID: 18692983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.